[Mindray Announces Preliminary 2012 Operating Results and 2013 Net Revenue Guidance SHENZHEN, China, January 7, 2013 — Mindray Medical International Limited (“Mindray,” NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2012. The company also provided net revenue guidance for 2013. For the year]

[Mindray Announces Preliminary 2012 Operating Results and 2013 Net Revenue Guidance SHENZHEN, China, January 7, 2013 — Mindray Medical International Limited (“Mindray,” NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2012. The company also provided net revenue guidance for 2013. For the year]

[Mindray intends to vigorously defend the actions. 2 Mindray Medical International Limited 3 6-K 1 d458772d6k.htm FORM 6-K]

[Mindray Announces Preliminary 2012 Operating Results and 2013 Net Revenue Guidance STYLE="font-family:Times New Roman" SIZE="2"> SHENZHEN, China, January7, 2013 Mindray Medical International Limited (Mindray, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December31, 2012. Thempanyso provided net revenue guidance for]

[Mindray intends to vigorously defend the actions. 2 Mindray Medical International Limited 3 FORM 6-K d458772d6k.htm 1 6-K]